Gardasil Trial Termination Is More Good News For Merck
This article was originally published in The Pink Sheet Daily
Executive Summary
Data and safety monitoring board’s recommendation to switch placebo patients in FUTURE studies to the vaccine comes on the heels of an “approvable” letter for Novartis’ potential Januvia competitor Galvus.